![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » NEW ROGAINE FOAM FEATURES CONNETICS' PROPRIETARY VERSAFOAM DELIVERY TECHNOLOGY
NEW ROGAINE FOAM FEATURES CONNETICS' PROPRIETARY VERSAFOAM DELIVERY TECHNOLOGY
Connetics Corporation, a specialty pharmaceutical company that develops and commercializes dermatology products, announces the use of its proprietary VersaFoam technology in Pfizer Consumer Healthcare's new Men's Rogaine Foam, now available wherever Rogaine is sold. In January 2006, Pfizer received FDA approval for Men's Rogaine Foam (minoxidil, 5%) developed under a license from Connetics' VersaFoam technology.
Business
Wire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct